6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Naloxone
It is an opioid antagonist, which means that it inhibits or reverses the effects of opioid medications. It is mostly used to treat opioid drug overdoses due to its antagonistic properties. Naloxone binds to albumin at a rate of around 45%, although it also strongly interacts with other proteins. In order to stop the effects of opioid drugs, naloxone temporarily inhibits opioid receptors. Because naloxone cannot be used to get high, there is minimal risk that it will be taken without a prescription. There is no evidence that long-term naloxone use can have harmful physiological effects or cause dependence. Users of naloxone do not develop tolerance, and the drug is not known to have contributed to any overdose deaths. This condition primarily affects people in their 20s and 30s. The prodromal phase refers to the time before symptoms appear.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Jana Furstova
Palacký University Olomouc, Czech Republic
Alexander Kharibegashvil
Telavi State University, GeorgiaSubmit your abstract Today
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Integrative addiction and mental health wellness lecture
John Giordano, Life Enhancement Recovery Center, United States
Title : Step one therapy
Ashton Christopher, Center for Recovery, Canada
Title : Addiction rehabilitation & recovery: Pathways to healing and resilience
Sindu Padmanabhan, Bharathiar University, India
Title : Stress-induced trauma syndrome in Chinese teenagers
Daniel Sun, Westminster Theological Seminary, United States
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States